Clinical and molecular characteristics of carnitineacylcarnitine translocase deficiency with c.270delC and a novel c.408C>A variant
Background. Carnitine-acylcarnitine translocase deficiency (CACTD) is a rare, autosomal recessive, and highly lethal fatty acid oxidation (FAO) disorder caused by defective acylcarnitine transport across the mitochondrial membrane. CACTD is characterized by severe episodes of hypoglycemia and...
Saved in:
| Main Authors: | Berrak Bilginer Gürbüz, Didem Yücel Yılmaz, Rıza Köksal Özgül, Can Koşukcu, Ali Dursun, Hatice Serap Sivri, Turgay Coşkun, Ayşegül Tokatlı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2021-08-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/348 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homozygous slc25a20 zebrafish mutant reveals insights into carnitine-acylcarnitine translocase deficiency pathogenesis
by: Ryuichi Hishida, et al.
Published: (2024-12-01) -
Rational Design, Synthesis, and In Vitro Activity of Heterocyclic Gamma-Butyrobetaines as Potential Carnitine Acetyltransferase Inhibitors
by: Savina Stoyanova, et al.
Published: (2025-02-01) -
Assessment and Application of Acylcarnitines Summations as Auxiliary Quantization Indicator for Primary Carnitine Deficiency
by: Haijuan Zhi, et al.
Published: (2025-06-01) -
Features of carnitine metabolism in young athletes
by: A. S. Samoilov, et al.
Published: (2023-02-01) -
Rational Design, Synthesis and In Vitro Activity of Diastereomeric <i>Cis</i>-/<i>Trans</i>-3-Substituted-3,4-Dihydroisocoumarin-4-Carboxylic Acids as Potential Carnitine Acetyltransferase Inhibitors
by: Savina Stoyanova, et al.
Published: (2025-07-01)